NO20083789L - Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel - Google Patents

Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel

Info

Publication number: NO20083789L
Authority: NO; Norway
Prior art keywords: vaginal; vulvar; prevention; treatment; conjugated estrogens
Prior art date: 2006-04-05

Application number

NO20083789A

Other languages

English (en)

Norwegian (no)

Inventor

Michael J Gast

Eileen Helzner

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-05

Filing date

2008-09-03

Publication date

2008-09-30

2008-09-03 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-09-30 Publication of NO20083789L publication Critical patent/NO20083789L/no

Links

238000000034 method Methods 0.000 title abstract 4
206010030247 Oestrogen deficiency Diseases 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
229940035811 conjugated estrogen Drugs 0.000 abstract 4
206010003694 Atrophy Diseases 0.000 abstract 2
230000037444 atrophy Effects 0.000 abstract 2
239000000262 estrogen Substances 0.000 abstract 2
229940011871 estrogen Drugs 0.000 abstract 2
208000004746 Atrophic Vaginitis Diseases 0.000 abstract 1
206010003693 Atrophic vulvovaginitis Diseases 0.000 abstract 1
208000004483 Dyspareunia Diseases 0.000 abstract 1
-1 MPA Chemical compound 0.000 abstract 1
208000003251 Pruritus Diseases 0.000 abstract 1
206010047791 Vulvovaginal dryness Diseases 0.000 abstract 1
206010056530 Vulvovaginal pruritus Diseases 0.000 abstract 1
WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000004064 dysfunction Effects 0.000 abstract 1
230000007803 itching Effects 0.000 abstract 1
201000010808 postmenopausal atrophic vaginitis Diseases 0.000 abstract 1
239000000583 progesterone congener Substances 0.000 abstract 1
230000009885 systemic effect Effects 0.000 abstract 1
201000006669 vulvar dystrophy Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20083789A 2006-04-05 2008-09-03 Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel NO20083789L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US78951706P	2006-04-05	2006-04-05
PCT/US2007/066042 WO2007118135A2 (fr)	2006-04-05	2007-04-05	Procédés de prévention et de traitement de pathologies associées à une déficience locale en œstrogènes

Publications (1)

Publication Number	Publication Date
NO20083789L true NO20083789L (no)	2008-09-30

Family

ID=38523460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20083789A NO20083789L (no)	2006-04-05	2008-09-03	Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel

Country Status (16)

Country	Link
US (1)	US20070238713A1 (fr)
EP (1)	EP2004200A2 (fr)
JP (1)	JP2009532505A (fr)
KR (1)	KR20080108120A (fr)
CN (1)	CN101415427A (fr)
AU (1)	AU2007234841A1 (fr)
BR (1)	BRPI0709924A2 (fr)
CA (1)	CA2644913A1 (fr)
CR (1)	CR10259A (fr)
EC (1)	ECSP088796A (fr)
GT (1)	GT200800205A (fr)
IL (1)	IL193810A0 (fr)
MX (1)	MX2008012880A (fr)
NO (1)	NO20083789L (fr)
RU (1)	RU2008136024A (fr)
WO (1)	WO2007118135A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2381947A4 (fr) *	2008-12-23	2012-08-22	Quest Diagnostics Invest Inc	Dosage par spectrométrie de masse pour des composés strogéniques
RS62297B1 (sr)	2011-11-23	2021-09-30	Therapeuticsmd Inc	Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja)	2014-05-22	2017-06-22	セラピューティックスエムディーインコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ，Ｉｎｃ．	天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
US9931349B2 (en)	2016-04-01	2018-04-03	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010034340A1 (en) *	2000-03-20	2001-10-25	American Home Products Corporation	Hormone replacement therapy
IL157943A0 (en) *	2001-03-16	2004-03-28	Wyeth Corp	Estrogen replacement therapy
EP1390038A2 (fr) *	2001-05-16	2004-02-25	Endeavor Pharmaceuticals	Traitement d'etats lies a un deficit en hormones par administration de progestatifs

2007
- 2007-04-05 KR KR1020087024302A patent/KR20080108120A/ko not_active Withdrawn
- 2007-04-05 CN CNA2007800124125A patent/CN101415427A/zh not_active Withdrawn
- 2007-04-05 US US11/696,917 patent/US20070238713A1/en not_active Abandoned
- 2007-04-05 WO PCT/US2007/066042 patent/WO2007118135A2/fr not_active Ceased
- 2007-04-05 BR BRPI0709924-0A patent/BRPI0709924A2/pt not_active Application Discontinuation
- 2007-04-05 EP EP07760168A patent/EP2004200A2/fr not_active Withdrawn
- 2007-04-05 AU AU2007234841A patent/AU2007234841A1/en not_active Abandoned
- 2007-04-05 RU RU2008136024/14A patent/RU2008136024A/ru not_active Application Discontinuation
- 2007-04-05 JP JP2009504473A patent/JP2009532505A/ja active Pending
- 2007-04-05 MX MX2008012880A patent/MX2008012880A/es unknown
- 2007-04-05 CA CA002644913A patent/CA2644913A1/fr not_active Abandoned
2008
- 2008-08-28 CR CR10259A patent/CR10259A/es not_active Application Discontinuation
- 2008-09-01 IL IL193810A patent/IL193810A0/en unknown
- 2008-09-03 NO NO20083789A patent/NO20083789L/no not_active Application Discontinuation
- 2008-10-02 GT GT200800205A patent/GT200800205A/es unknown
- 2008-10-06 EC EC2008008796A patent/ECSP088796A/es unknown

Also Published As

Publication number	Publication date
BRPI0709924A2 (pt)	2011-07-26
CN101415427A (zh)	2009-04-22
RU2008136024A (ru)	2010-05-10
KR20080108120A (ko)	2008-12-11
MX2008012880A (es)	2008-10-13
ECSP088796A (es)	2008-11-27
WO2007118135A3 (fr)	2008-04-24
WO2007118135A2 (fr)	2007-10-18
JP2009532505A (ja)	2009-09-10
CR10259A (es)	2008-11-26
IL193810A0 (en)	2009-08-03
EP2004200A2 (fr)	2008-12-24
AU2007234841A1 (en)	2007-10-18
GT200800205A (es)	2009-05-15
CA2644913A1 (fr)	2007-10-18
US20070238713A1 (en)	2007-10-11

Publication	Publication Date	Title
NO20083789L (no)	2008-09-30	Fremgangsmater for forebygging og behandling av tilstander som oppstar ved lokal ostrogen mangel
GEP20156281B (en)	2015-05-11	Orally administered corticosteroid compositions
WO2007098113A3 (fr)	2008-10-16	Inhibition de ccr3 pour angiogenèse oculaire et dégénérescence maculaire
WO2009064460A3 (fr)	2009-07-30	Systèmes de délivrance aux voies gastro-intestinales
MA33197B1 (fr)	2012-04-02	Inhibiteurs de tripeptide époxy cétone protéases cristallines
WO2007052289A3 (fr)	2007-12-27	Nouvelle composition de comprime dispersible
WO2007143607A3 (fr)	2008-02-21	Procédé de traitement de la vaginite atrophique
NO20090119L (no)	2009-03-20	Sammensetning omfattende nanopartikulaert meloxicam og hydrokodon med kontrollert frigivelse
WO2008122965A3 (fr)	2008-12-24	Compositions pharmaceutiques à base de cyclosporine
MX2008011633A (es)	2008-12-16	Aminoquinolonas como inhibidores de gsk-3.
WO2010146179A3 (fr)	2011-04-14	Composition pharmaceutique solide comprenant du rivaroxaban
NI201000183A (es)	2012-06-06	Regímenes de dosificación de antiprogestina.
AR059174A1 (es)	2008-03-12	Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
TNSN08451A1 (en)	2010-04-14	Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
NO20090158L (no)	2009-03-20	Sammensetning omfattende nanopartikulaer naproxen og kontrollert frigivelseshydrokarbon
TW200738269A (en)	2007-10-16	Oral delivery of therapeutic agents using tight junction agonists
NO20070139L (no)	2007-03-08	Heterosykliske derivater for behandling av hyperlipidemi og relaterte sykdommer
MX2010005837A (es)	2010-10-07	Composiciones farmaceuticas para tratar la depresion y la ansiedad.
WO2006023496A3 (fr)	2007-03-15	Compositions de creme vaginale, kits correspondants et procedes d'utilisation
WO2009035634A3 (fr)	2009-06-04	Cyanoaminoquinolones et tétrazoloaminoquinolones en tant qu'inhibiteurs de gsk-3
NO20090467L (no)	2009-03-19	Tablettformuleringer med umiddelbar frigivelse av en trombinreseptorantagonist.
EP1857112A4 (fr)	2009-07-01	Composition anticancer en administration orale comprenant un liposome qui contient des phytosterols et prevention ou traitement du cancer avec le liposome
NO20082729L (no)	2008-07-08	Etanol-presipiterte Phaseolus vulgaris ekstrakter, deres anvendelse og formuleringer
WO2009060451A3 (fr)	2010-03-11	Dérivés de s-alkylisothiouronium utilisés dans le traitement des troubles liés à l'hypercontractilité utérine
WO2010104691A3 (fr)	2011-01-13	Composés ostrogéniques et leurs procédés d'utilisation

Legal Events

Date	Code	Title	Description
2010-11-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application